A nasal pharmaceutical composition comprising a decongestant compound selected from xylometazoline or a pharmaceutically acceptable salt of xylometazoline, oxymetazoline or a pharmaceutically acceptable salt of oxymetazoline, menthol; dexpanthenol and hyaluronic acid or a pharmaceutically acceptable salt of hyaluronic acid.